Principal Investigator
BeiGene (Beijing) Ltd., Co., China (People's Republic)
Dr Yue Wu received her Bachelor and Master’s Degree in Pharmaceutical Sciences and Clinical Pharmacy in Peking University in China, and her PhD Degree in Pharmacology in University of Adelaide in Australia in 2011. After graduation, Dr Wu joined Novo Nordisk Research Center China as a Research Information Scientist, and later joined the Department of Pharmacology as a Senior Scientist. During the 7 years in Novo Nordisk, Dr Wu focused on new drug target evaluation in diabetes, obesity, and atherosclerosis animal models, as well as pharmacokinetics studies in small and large animals. She also led several internal and external collaboration projects. In 2019, Dr Wu joined the DMPK Department in BeiGene, specialized in PK/PD modeling and human efficacious dose prediction. Meanwhile, Dr Wu also led DMPK studies in discovery projects.